• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶7以依赖DKK1的方式诱导曲妥珠单抗-美坦新偶联物耐药并导致胃腺癌预后不良。

MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma a DKK1-Dependent Manner.

作者信息

Li Hua, Xu Xin, Liu Yang, Li Shunle, Zhang Di, Meng Xiaofen, Lu Le, Li Yiming

机构信息

Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.

出版信息

Anticancer Agents Med Chem. 2018;18(14):2010-2016. doi: 10.2174/1871520619666181203111329.

DOI:10.2174/1871520619666181203111329
PMID:30501604
Abstract

BACKGROUND

Gastric adenocarcinoma is one of the most common and lethal cancer types and is known as the second leading cause of cancer-related death of Asian adults, early diagnosis based on either pathology or molecular biology could be one of the most efficient ways to improve the outcomes of gastric adenocarcinoma patients.

METHODS

Quantitative Real-Time PCR and Western-blot were used in detection of mRNA and protein expression. Lentivirus infection was used to overexpression or knock down target gene. Alarma blue assay was used to monitor cells proliferation. Flow cytometry analysis was performed to test protein expression and apoptosis level. Immunohistochemistry was used to identify protein expression in tissue. Statistical differences between two groups are evaluated by two-tailed t-tests. The comparison among multiple groups is performed by one-way Analysis of Variance (ANOVA) followed by Dunnett's posttest. The statistical significance of the Kaplan-Meier survival plot is determined by log-rank analysis.

RESULTS

MMP7 as one of the most up-regulated genes in T-DM1 resistant NCI-N87 gastric adenocarcinoma cells compared to matched naïve cell lines. T-DM1 resistant NCI-N87 cell lines by exposed to T-DM1 in vitro. Exogenous overexpression of MMP7 promotes T-DM1 resistance and tumor growth in NCI-N87 cell lines while MMP7 knockdown enhanced sensitivity to T-DM1 in T-DM1 resistant NCI-N87 cell lines established previously. MMP7 was enriched in high WHO grade GC samples and implies poor outcomes for these patients. DKK1 as one of the most correlated genes to MMP7 in gastric adenocarcinoma and knock-down of DKK1 or inhibition of Wnt/β-catenin pathway led to a decreased expression of MMP7 and resistance to T-DM1.

CONCLUSION

DKK1 and Wnt/β-catenin-dependent activation of MMP7 induces T-DM1 resistance and leads to the poor prognosis of gastric adenocarcinoma, which might be a novel potential therapeutical target for T-DM1 resistant gastric adenocarcinoma.

摘要

背景

胃腺癌是最常见且致命的癌症类型之一,是亚洲成年人癌症相关死亡的第二大主要原因,基于病理学或分子生物学的早期诊断可能是改善胃腺癌患者治疗效果的最有效方法之一。

方法

采用定量实时聚合酶链反应(qRT-PCR)和蛋白质免疫印迹法检测mRNA和蛋白质表达。利用慢病毒感染过表达或敲低靶基因。采用阿尔玛蓝检测法监测细胞增殖。进行流式细胞术分析以检测蛋白质表达和细胞凋亡水平。采用免疫组织化学法鉴定组织中的蛋白质表达。两组间的统计学差异采用双侧t检验进行评估。多组间的比较采用单因素方差分析(ANOVA),随后进行Dunnett事后检验。Kaplan-Meier生存曲线的统计学显著性通过对数秩分析确定。

结果

与匹配的未处理细胞系相比,MMP7是曲妥珠单抗-美坦新偶联物(T-DM1)耐药的NCI-N87胃腺癌细胞中上调最明显的基因之一。通过体外暴露于T-DM1建立T-DM1耐药的NCI-N87细胞系。MMP7的外源性过表达促进NCI-N87细胞系对T-DM1的耐药性和肿瘤生长,而在先前建立的T-DM1耐药的NCI-N87细胞系中敲低MMP7可增强对T-DM1的敏感性。MMP7在世界卫生组织(WHO)高分级胃癌样本中富集,提示这些患者预后不良。DKK1是胃腺癌中与MMP7相关性最强的基因之一,敲低DKK1或抑制Wnt/β-连环蛋白信号通路可导致MMP7表达降低及对T-DM1耐药性下降。

结论

DKK1和Wnt/β-连环蛋白依赖性激活MMP7诱导T-DM1耐药并导致胃腺癌预后不良,这可能是T-DM1耐药胃腺癌的一个新的潜在治疗靶点。

相似文献

1
MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma a DKK1-Dependent Manner.基质金属蛋白酶7以依赖DKK1的方式诱导曲妥珠单抗-美坦新偶联物耐药并导致胃腺癌预后不良。
Anticancer Agents Med Chem. 2018;18(14):2010-2016. doi: 10.2174/1871520619666181203111329.
2
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.DS-8201a,一种新型的 HER2 靶向抗体药物偶联物,包含一种新型的 DNA 拓扑异构酶 I 抑制剂,克服了曲妥珠单抗-美坦新偶联物(T-DM1)耐药的 HER2 阳性胃癌。
Int J Cancer. 2017 Oct 15;141(8):1682-1689. doi: 10.1002/ijc.30870. Epub 2017 Jul 12.
3
Aberrant intracellular metabolism of T-DM1 confers T-DM1 resistance in human epidermal growth factor receptor 2-positive gastric cancer cells.曲妥珠单抗-美坦新偶联物(T-DM1)异常的细胞内代谢赋予人表皮生长因子受体2阳性胃癌细胞对T-DM1的抗性。
Cancer Sci. 2017 Jul;108(7):1458-1468. doi: 10.1111/cas.13253. Epub 2017 May 23.
4
Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer.无标记定量蛋白质组学联合生物学验证揭示 Wnt/β-连环蛋白通路的激活导致胃癌对曲妥珠单抗耐药。
Int J Mol Sci. 2018 Jul 6;19(7):1981. doi: 10.3390/ijms19071981.
5
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.曲妥珠单抗-美坦新偶联物(T-DM1)联合帕妥珠单抗在 HER2 阳性胃癌模型中的抗肿瘤活性增强。
Oncol Rep. 2013 Sep;30(3):1087-93. doi: 10.3892/or.2013.2547. Epub 2013 Jun 19.
6
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.FGFR3 自分泌环路维持胃癌患者对曲妥珠单抗的获得性耐药。
Clin Cancer Res. 2016 Dec 15;22(24):6164-6175. doi: 10.1158/1078-0432.CCR-16-0178. Epub 2016 Jun 7.
7
Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1.表达Heregulin的HER2阳性乳腺癌和胃癌对抗HER2药物拉帕替尼、曲妥珠单抗和T-DM1表现出异质性敏感性。
Oncotarget. 2016 Dec 20;7(51):84860-84871. doi: 10.18632/oncotarget.12743.
8
DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.DKK1 通过β-catenin/MMP7 信号通路促进肝癌细胞迁移和侵袭。
Mol Cancer. 2013 Dec 10;12:157. doi: 10.1186/1476-4598-12-157.
9
Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.Dickkopf-3(Dkk3)通过Wnt/β-连环蛋白信号通路诱导顺铂耐药肺腺癌细胞凋亡。
Oncol Rep. 2015 Mar;33(3):1097-106. doi: 10.3892/or.2014.3704. Epub 2014 Dec 30.
10
Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.GPR34 表达上调通过 PI3K/PDK1/AKT 通路影响人胃腺癌的进展和预后。
Histol Histopathol. 2013 Dec;28(12):1629-38. doi: 10.14670/HH-28.1629. Epub 2013 Jul 9.

引用本文的文献

1
Fighting HER2 in Gastric Cancer: Current Approaches and Future Landscapes.胃癌中针对人表皮生长因子受体2(HER2)的治疗:当前方法与未来前景
Int J Mol Sci. 2025 Jul 28;26(15):7285. doi: 10.3390/ijms26157285.
2
Mechanism of etoposide resistance in small cell lung cancer and the potential therapeutic options.小细胞肺癌依托泊苷耐药的机制及潜在治疗选择。
Med Oncol. 2025 Apr 21;42(5):167. doi: 10.1007/s12032-025-02718-0.
3
Antibody-drug conjugates in gastric cancer: from molecular landscape to clinical strategies.胃癌中的抗体药物偶联物:从分子格局到临床策略
Gastric Cancer. 2024 Sep;27(5):887-906. doi: 10.1007/s10120-024-01529-y. Epub 2024 Jul 4.
4
HER2 advanced gastric cancer: Current state and opportunities (Review).人表皮生长因子受体 2 阳性晚期胃癌:现状与机遇(综述)。
Int J Oncol. 2024 Apr;64(4). doi: 10.3892/ijo.2024.5624. Epub 2024 Feb 23.
5
Clinical Significance of MMP7 Levels in Colorectal Cancer Patients Receiving FOLFOX4 Chemotherapy Treatment.接受FOLFOX4化疗的结直肠癌患者中MMP7水平的临床意义
Int J Gen Med. 2023 Jun 26;16:2671-2678. doi: 10.2147/IJGM.S416363. eCollection 2023.
6
Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers.他汀类药物增强了抗 HER2 放射性配体疗法在耐药性胃癌中的疗效。
Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220413120. doi: 10.1073/pnas.2220413120. Epub 2023 Mar 27.
7
An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas.一种免疫相关预后特征可预测胃腺癌的总生存期。
Front Genet. 2022 May 23;13:903393. doi: 10.3389/fgene.2022.903393. eCollection 2022.
8
Screening and Identification of Key Biomarkers of Gastric Cancer: Three Genes Jointly Predict Gastric Cancer.胃癌关键生物标志物的筛选与鉴定:三个基因联合预测胃癌
Front Oncol. 2021 Aug 17;11:591893. doi: 10.3389/fonc.2021.591893. eCollection 2021.
9
Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill.构象特异性抑制性抗MMP-7单克隆抗体使胰腺导管腺癌细胞对化疗细胞杀伤敏感。
Cancers (Basel). 2021 Apr 2;13(7):1679. doi: 10.3390/cancers13071679.
10
Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer.靶向 T-DM1 促进的自噬抗肿瘤作用治疗 HER2 阳性胃癌。
Cell Death Dis. 2021 Mar 17;12(4):288. doi: 10.1038/s41419-020-03349-1.